Common menu bar links
- About BDRS
- Doing Business with NRC-IBS
- Licensing Opportunities
- Partnered Technologies
- Contact us
NRC-IBS expertise in Vaccines, Therapeutics, Bioproducts, Diagnostics leads to Commercial Success, Licenses, Spin-offs, Collaboration, Fee For Service
Vaccines - License
- Meningitis $500M+
Worldwide Sales meningitis C Vaccine licensed to Multinationals
Therapeutics - Spin-Off Company
- Zelos $100M+
Spin-Off Company, Osteoporosis Treatment, completed Phase II Clinical Trial funded by Major VC Firms
Bioproducts Collaborations
- Xylanase $45M+
Pulp-Bleaching Enzyme, developed with Iogen Corporation
Diagnostics - Fee For Service
- Ion Channel Drug Testing
Patch-Clamp/MEA Validation, Ion Fluorescent Imaging for Biopharma
